JP2013511566A5 - - Google Patents

Download PDF

Info

Publication number
JP2013511566A5
JP2013511566A5 JP2012540414A JP2012540414A JP2013511566A5 JP 2013511566 A5 JP2013511566 A5 JP 2013511566A5 JP 2012540414 A JP2012540414 A JP 2012540414A JP 2012540414 A JP2012540414 A JP 2012540414A JP 2013511566 A5 JP2013511566 A5 JP 2013511566A5
Authority
JP
Japan
Prior art keywords
protein
factor
pegylated protein
buffer
purified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012540414A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013511566A (ja
JP5827955B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/068112 external-priority patent/WO2011064247A1/en
Publication of JP2013511566A publication Critical patent/JP2013511566A/ja
Publication of JP2013511566A5 publication Critical patent/JP2013511566A5/ja
Application granted granted Critical
Publication of JP5827955B2 publication Critical patent/JP5827955B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012540414A 2009-11-24 2010-11-24 Peg化タンパク質の精製方法 Active JP5827955B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP09176881 2009-11-24
EP09176881.2 2009-11-24
US26448609P 2009-11-25 2009-11-25
US61/264,486 2009-11-25
PCT/EP2010/068112 WO2011064247A1 (en) 2009-11-24 2010-11-24 Method of purifying pegylated proteins

Publications (3)

Publication Number Publication Date
JP2013511566A JP2013511566A (ja) 2013-04-04
JP2013511566A5 true JP2013511566A5 (enExample) 2014-01-16
JP5827955B2 JP5827955B2 (ja) 2015-12-02

Family

ID=41401820

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012540414A Active JP5827955B2 (ja) 2009-11-24 2010-11-24 Peg化タンパク質の精製方法

Country Status (5)

Country Link
US (1) US8697844B2 (enExample)
EP (1) EP2504349B1 (enExample)
JP (1) JP5827955B2 (enExample)
CN (2) CN107383158A (enExample)
WO (1) WO2011064247A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2101821T3 (da) 2006-12-15 2014-10-06 Baxter Healthcare Sa Faktor VIIA-(poly)sialinsyre-konjugat med forlænget halveringstid in vivo
EP3081233B1 (en) 2009-07-27 2020-12-23 Baxalta GmbH Glycopolysialylation of proteins other than blood coagulation proteins
RU2744370C2 (ru) 2009-07-27 2021-03-05 Баксалта Инкорпорейтед Конъюгаты белков свертывания крови
US8809501B2 (en) 2009-07-27 2014-08-19 Baxter International Inc. Nucleophilic catalysts for oxime linkage
US8642737B2 (en) 2010-07-26 2014-02-04 Baxter International Inc. Nucleophilic catalysts for oxime linkage
BR112012001814A8 (pt) 2009-07-27 2018-02-06 Baxalta GmbH Conjugados de proteína de coagulação sanguínea
ES2800983T3 (es) 2010-12-22 2021-01-07 Baxalta GmbH Materiales y métodos para conjugar un derivado de ácido graso soluble en agua con una proteína
KR102020995B1 (ko) * 2017-10-30 2019-09-16 한국코러스 주식회사 콜로니자극인자와 폴리올이 접합된 접합물을 고수율로 제조하는 방법
PL3731873T3 (pl) * 2017-12-29 2022-04-25 F. Hoffmann-La Roche Ag Sposób dostarczania kompozycji pegylowanego białka
CN111801120A (zh) 2017-12-29 2020-10-20 豪夫迈·罗氏有限公司 用于提供聚乙二醇化蛋白质组合物的方法
US12208142B2 (en) 2017-12-29 2025-01-28 Hoffmann-La Roche Inc. Process for providing PEGylated protein composition
US12559518B2 (en) 2020-12-08 2026-02-24 Tonghua Anrate Biopharmaceutical Co., Ltd Method for purification of recombinant proteins

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040731A1 (en) * 1995-06-07 1996-12-19 Mount Sinai School Of Medicine Of The City University Of New York Pegylated modified proteins
US5714583A (en) 1995-06-07 1998-02-03 Genetics Institute, Inc. Factor IX purification methods
ATE370961T1 (de) * 1998-05-06 2007-09-15 Genentech Inc Reinigung von antikörpern durch ionenaustauschchromatographie
ES2228052T3 (es) 1998-06-01 2005-04-01 Genentech, Inc. Separacion demonomeros de anticuerpos de sus multimeros utilizando cromatografia de intercambio de iones.
US7179617B2 (en) 2001-10-10 2007-02-20 Neose Technologies, Inc. Factor IX: remolding and glycoconjugation of Factor IX
EP2292273A3 (en) 2001-10-10 2011-11-23 BioGeneriX AG Remodeling and glycoconjugation of peptides
US7795210B2 (en) 2001-10-10 2010-09-14 Novo Nordisk A/S Protein remodeling methods and proteins/peptides produced by the methods
US7265084B2 (en) 2001-10-10 2007-09-04 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
US7473680B2 (en) 2001-11-28 2009-01-06 Neose Technologies, Inc. Remodeling and glycoconjugation of peptides
US7470779B2 (en) * 2002-09-20 2008-12-30 Pfizer Inc. Process for decreasing aggregate levels of pegylated protein
CA2522345A1 (en) 2003-04-09 2004-11-18 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
JP4738346B2 (ja) * 2003-12-03 2011-08-03 ノヴォ ノルディスク アー/エス GlycoPEG化された第IX因子
US20060040856A1 (en) 2003-12-03 2006-02-23 Neose Technologies, Inc. Glycopegylated factor IX
US20080255026A1 (en) 2005-05-25 2008-10-16 Glycopegylated Factor 1X Glycopegylated Factor Ix
MX2008002395A (es) * 2005-08-19 2008-03-18 Neose Technologies Inc Factor vii y factor viia glicopegilados.
US20070105755A1 (en) * 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
US8399632B2 (en) 2007-02-28 2013-03-19 Baxter International Inc. Method for the purification of recombinant blood coagulation factor IX enriched in sulfated and/or phosphorylated molecules
WO2008119815A1 (en) * 2007-04-02 2008-10-09 Novo Nordisk A/S Subcutaneous administration of coagulation factor ix

Similar Documents

Publication Publication Date Title
JP2013514073A5 (enExample)
EA201171199A1 (ru) Способ очистки рекомбинантного фсг
ES2923018T3 (es) Métodos de purificación de ARN
JP2011525523A5 (enExample)
JP2012018171A5 (enExample)
PH12020500027A1 (en) Purification of iduronate-2-sulfatase
JP2012518034A5 (enExample)
GB2443505B (en) Nucleic acid purification method
JP2013500711A5 (enExample)
JP2011510303A5 (enExample)
JP2016519137A5 (enExample)
JP2013528183A5 (enExample)
RU2011102437A (ru) Способ очистки фактора свертывания крови viii
FI4039249T3 (fi) Seriiniproteaasien poistaminen hienojakoisella piidioksidilla tehtävällä käsittelyllä
JP2013503877A5 (enExample)
WO2010151632A8 (en) Protein purification by caprylic acid (octanoic acid ) precipitation
RU2014111820A (ru) Способы элиминации вируса
JP2012510500A5 (enExample)
JP2014507368A5 (enExample)
FI3395423T3 (fi) Vuotaneen affiniteettipuhdistusligandin poistaminen
CN103725664A (zh) 一种高度纯化激肽释放酶的方法
TWI679209B (zh) 使用陽離子交換層析法純化同功抗體之方法
JP2014193838A5 (enExample)
JP2011097940A5 (enExample)
JP2008517046A5 (enExample)